Healthcare Pharmaceutical Biotech

Report from the Annual General Meeting 2026 of IRLAB Therapeutics AB

June 30, 2026 11:30 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB held its Annual General Meeting today, Tuesday 30 June 2026, at Biotech center in Gothenburg. The following main resolutions were made at the Annual General Meeting. Adoption of income statement and balance sheet as well as consolidated income statement and consolidated balance sheet The Annual General Meeting adopted the income statement and the balance sheet as well as the...

Read more

Neuro20 Technologies and The Walk Foundation Partner to Launch Home-Based Neurorehabilitation Initiative

June 30, 2026 11:10 AM

Neuro20 Technologies Corp., an emerging leader in advanced electroceutical medicine, today announced a strategic partnership with The Walk Foundation to tackle the steep clinical validation and commercial accessibility barriers currently holding back breakthrough neurorehabilitation. The collaboration introduces a tactical Patient Access Initiative. This program utilizes charitable funding and donor sponsorships to place FDA-cleared Neuro20 PRO...

Read more

Tribun Health Announces CaloPix(R) 6, Its First IVDR-Certified Version for Routine Diagnostic Use

June 30, 2026 9:30 AM

Tribun Health, a global leader in digital pathology and artificial intelligence orchestration software solutions, today announced the availability of CaloPix® 6, the first version of its platform certified under the European In Vitro Diagnostic Medical Devices Regulation (IVDR) for routine diagnostic use. This new milestone marks the culmination of several years of investment in quality, cybersecurity, risk management, and regulatory excellence....

Read more

Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering

June 30, 2026 9:25 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced that it has priced a public offering of securities as described below for aggregate gross proceeds to the Company of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses payable by the Company. The offering consists of...

Read more

Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump

June 30, 2026 9:15 AM

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings. This milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Rolls Out Visually Stunning Super-Charged Version of Snapshot Recipes Mobile App

June 30, 2026 9:11 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a comprehensive redesign and upgrade to its flagship consumer wellness app, Snapshot Recipes, transforming it into a visually stunning, high-speed AI culinary powerhouse. Learn more about the app at https://snapshotrecipes.app. The complete visual overhaul introduces a bold, artistic, and modern creative design that elevates the user experience with mouth-watering imagery, intuitive...

Read more

NCQA Names Dr. Ari Robicsek as Inaugural Chief Medical Officer

June 30, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) today announced the appointment of Ari Robicsek, MD, as its inaugural Chief Medical Officer (CMO). Dr. Robicsek joined the organization on June 29, 2026, bringing more than two decades of experience at the intersection of clinical medicine, data science, healthcare analytics and innovation to deepen NCQA's clinical leadership and accelerate its quality modernization agenda. "The creation of the...

Read more

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

June 30, 2026 9:00 AM

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Microdacyn® Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. Under this new clearance, Microdacyn Wound Irrigation Solution can be used under the...

Read more

Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)

June 30, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar") family company Napo Pharmaceuticals (Napo) today provided a recap of presentations of the oral liquid crofelemer as adjunctive therapy in pediatric intestinal failure (IF) patients at the 58th Annual European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN) Meeting in Lille, France. Napo provided additional data from ongoing investigational studies with oral liquid crofelemer...

Read more

Rivia Mind Opens Montclair Office to Support Continued Access to Mental Health Care in New Jersey

June 30, 2026 8:45 AM

Rivia Mind, a mental health practice committed to compassionate, evidence-based care, today announced the continued expansion of its New Jersey services through its Montclair office. The new location represents the next stage of Rivia Mind's commitment to increasing access to outpatient mental health care and psychiatric medication management through a flexible hybrid model that combines in-person and virtual services. The new Montclair office...

Read more

Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model

June 30, 2026 8:30 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company focused on novel neuropeptide therapies for stress-related disorders, today announced the publication of new preclinical data for its lead candidate, PT00114, in the peer-reviewed journal Behavioural Pharmacology. In a well-established rodent model of chronic unpredictable stress, PT00114 reduced both physiological and behavioral markers of chronic stress...

Read more

CVS Health: The Health Screenings Men Shouldn't Skip - and How CVS Health Makes Them Easier

June 30, 2026 8:30 AM

Originally published on CVS Health Company Newsroom Key points Many men develop silent risks for heart disease and certain cancers sooner than they may realize. Preventive screenings can catch issues early, yet men are less likely than women to seek routine care. CVS Health offers convenient ways to get screened - from walk in clinics to virtual care and mobile health vans Why health screenings matter Taking care of health doesn't have to be...

Read more

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

June 30, 2026 8:05 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced it has been awarded a $1.5 million non-dilutive research grant from the Andy Hill Cancer Research Endowment (CARE) Fund under its Implementation and Outcomes Research program to support investigational new drug (IND)-enabling work...

Read more

Black Book Norway Provider Pulse Examines Shared-Record Interoperability, Clinician Workflow Burden and Frontline Trust

June 30, 2026 8:00 AM

Black Book Research today released findings from a focused Norway provider pulse survey of 99 clinicians, care delivery professionals, municipal provider respondents and health IT leaders, examining frontline experience with shared-record modernization, interoperability execution and clinical workflow performance. Black Book initiated the Norway provider pulse following its June 2026 European interoperability and EHDS readiness research, which...

Read more

Wellgistics Health Executive Chairman and President Exercise Warrants

June 30, 2026 7:40 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that its Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel have exercised all warrants previously issued to them in connection with the conversion of their outstanding salaries into common shares at $10 per...

Read more

Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing

June 30, 2026 7:05 AM

Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the life of people living with rare cancer conditions, today announced the filing of a new patent application for its first-in-class liver imaging drug Orviglance®. The patent application covers innovations related to packaging and manufacturing of Orviglance, which includes improving the usability for patients and healthcare professionals. Subject to approval and grant,...

Read more

SP Industries Inc. Leverages Bioz to Unify Scientific Validation Across Its Portfolio of Leading Brands

June 30, 2026 4:00 AM

Bioz, Inc., the leading scientific citation intelligence platform that transforms publications into measurable product validation and commercial impact, announced its collaboration with SP Industries Inc. (SP), a global provider of innovative laboratory equipment and solutions. By implementing Bioz Badges and the Bioz Content Hub across its website, SP is enhancing how researchers discover, evaluate, and engage with its portfolio of trusted...

Read more

MedMira Reports Third Quarter Results FY2026

June 29, 2026 8:00 PM

MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2026. Corporate update During Q3 FY2026, the Company continued to advance the regulatory approval process for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP). The Company received its initial feedback from Health Canada and remains confident that the new regulatory submission pathway will facilitate more efficient...

Read more

1933 Industries Reports Third Quarter 2026 Financial Results

June 29, 2026 5:46 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its third quarter financial results for the six and nine months ended April 30, 2026 and 2025 ("fiscal 2026"). All amounts expressed are in Canadian dollars. The Company owns 100%1 of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary centred on the...

Read more

Why Local Leadership is the Ultimate Remedy for Rural Healthcare

June 29, 2026 5:30 PM

It was mid-2023. Staff at Monroe County Hospital (MCH) in Forsyth, Georgia, population 4,384, had been told by their corporate management leaders that the hospital was going through their reserves quickly. Closing down was not only possible, they said, but likely. MCH wasn't ready to let this happen. So, in November 2023, they chose Aletheia Health Partners, a hospital management company focused on serving rural communities, to try to turn the...

Read more